SOHO China Limited (HKG:0410)

Orchard Therapeutics Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-113.44	-179.9	61.21	-131.1	529.57
Depreciation & Amortization	44.56	37.66	117.82	59.71	120.5
Gain (Loss) on Sale of Assets	0.01	0.01	0.15	0.37	-
Gain (Loss) on Sale of Investments	5.55	11.57	-79.49	-90.37	-28.8
Asset Writedown	133.88	191.26	-22.41	-289	-1,100
Change in Accounts Receivable	15.4	122.67	-257.81	-36.12	36.7
Change in Accounts Payable	159.13	214.57	-420.18	487.68	-120.39
Change in Other Net Operating Assets	35.46	11.17	78.89	-14.83	-22.07
Other Operating Activities	-14.34	46.35	401.23	-113.47	505.96
Operating Cash Flow	306.66	643.96	-135.19	56.26	209.04
Operating Cash Flow Growth	-52.38%	-	-	-73.09%	-68.31%
Acquisition of Real Estate Assets	-88.54	-74.37	-81.82	-164.77	-312.82
Sale of Real Estate Assets	92.25	171.98	370.87	0.31	84.06
Net Sale / Acq. of Real Estate Assets	3.71	97.62	289.06	-164.46	-228.76
Investment in Marketable & Equity Securities	-164	-3.82	1,343	904.89	-1,377
Other Investing Activities	6.08	0.62	24.91	16.98	26.38
Investing Cash Flow	-154.2	94.41	1,657	757.41	-1,579
Long-Term Debt Issued	-	-	-	500	2,305
Long-Term Debt Repaid	-340.97	-316.95	-1,934	-955.08	-1,791
Net Debt Issued (Repaid)	-340.97	-316.95	-1,934	-455.08	513.27
Issuance of Common Stock	-	-	-	-	6.46
Other Financing Activities	-	-	-	-	53.81
Foreign Exchange Rate Adjustments	8.67	2.32	22.94	-20.7	-13.51
Net Cash Flow	-179.84	423.74	-388.97	337.89	-810.03
Cash Interest Paid	769.08	765.71	815.4	908.41	941.17
Cash Income Tax Paid	141.95	198.69	71.68	530.43	511.07
Levered Free Cash Flow	151.38	571.29	1,529	1,290	-196.45
Unlevered Free Cash Flow	601.95	1,057	2,030	1,861	395.25
Change in Net Working Capital	9.44	-392.46	-1,159	-1,336	528.09

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.